Combating cancer immunotherapy resistance: a nano‐medicine perspective
Cancer Communications,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 10, 2025
Abstract
Cancer
immunotherapy
offers
renewed
hope
for
treating
this
disease.
However,
cancer
cells
possess
inherent
mechanisms
that
enable
them
to
circumvent
each
stage
of
the
immune
cycle,
thereby
evading
anti‐cancer
immunity
and
leading
resistance.
Various
functionalized
nanoparticles
(NPs),
modified
with
cationic
lipids,
pH‐sensitive
compounds,
or
photosensitizers,
exhibit
unique
physicochemical
properties
facilitate
targeted
delivery
therapeutic
agents
tumor
microenvironment
(TME).
These
NPs
are
engineered
modify
activity.
The
crucial
signal
transduction
pathways
by
which
counteract
resistance
outlined,
including
enhancing
antigen
presentation,
boosting
activation
infiltration
tumor‐specific
cells,
inducing
immunogenic
cell
death,
counteracting
immunosuppressive
conditions
in
TME.
Additionally,
review
summarizes
current
clinical
trials
involving
NP‐based
immunotherapy.
Ultimately,
it
highlights
potential
nanotechnology
advance
Language: Английский
ATP‐Triggered Ultrafine Iron Oxide Nanowires for Self‐Monitoring Tumor Therapy by T1‐Magnetic Resonance Imaging‐Guided •OH Generation
Zhengtao Xu,
No information about this author
Chen Wang,
No information about this author
Zhuangzhuang Zhao
No information about this author
et al.
Advanced Functional Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 13, 2025
Abstract
Theranostic
probes
that
integrate
diagnosis
and
treatment
together
are
considered
as
effective
tools
for
individual
therapy.
However,
the
separation
of
detection
components
limits
precise
assessment
therapeutic
efficacy.
Herein,
a
novel
self‐monitoring
probe
sensitively
responds
to
adenosine
triphosphate
(ATP)
was
developed
by
ultrafine
iron
oxide
nanowires
(UIONWs)
through
an
oleyl
amine‐assisted
way.
The
UIONWs,
with
diameter
1.5
nm
length
75
nm,
surface‐coordinated
amine.
UIONWs
can
be
decomposed
in
ATP‐containing
solution
expose
shielded
ions.
Consequently,
it
boost
peroxidase
(POD)
activity
activate
T
1
‐magnetic
resonance
imaging
(MRI)
signal
ATP.
In
addition,
rapidly
engulfed
into
cells
due
high
aspect
ratio.
improved
ATP
hydrogen
peroxide
(H
2
O
)
within
tumor
leads
higher
hydroxyl
radicals
(OH)
generation
inhibition.In
contrast,
normal
exhibit
lower
H
levels,
reducing
cytotoxicity
ensuring
safety.
Since
both
illumination
‐MRI
OH
ATP‐controlled,
this
work
raised
potential
way
self‐monitor
therapy
timely
feedback
on
effects.
Language: Английский